Macrocytic anemia medical therapy: Difference between revisions

Jump to navigation Jump to search
Priyamvada Singh (talk | contribs)
Created page with "{{Macrocytic anemia}} {{CMG}} ==Overview== '''Macrocytosis''' is the enlargement of red blood cells with near-constant haemoglobin concentration, and is defined by a [..."
 
Priyamvada Singh (talk | contribs)
Line 2: Line 2:
{{CMG}}
{{CMG}}
==Overview==
==Overview==
'''Macrocytosis''' is the enlargement of [[red blood cell]]s with near-constant [[haemoglobin]] concentration, and is defined by a [[mean corpuscular volume]] (MCV) of greater than 100 femtolitres (the precise criterion varies between laboratories).  
'''Macrocytosis''' is the enlargement of [[red blood cell]]s with near-constant [[haemoglobin]] concentration, and is defined by a [[mean corpuscular volume]] (MCV) of greater than 100 femtolitres (the precise criterion varies between laboratories).
==Treatment==
* Folate is administered 1mg QD.  Higher doses may be required in malabsorptive syndromes.  It is empirically given to those with SCD and those on HD.
* B12 must be given as a load then maintenance.  Most advocate 1000 mcg IM Qweek x4 then 100mcg/month.
* LDH falls in 2 days.  Hypokalemia requiring replacement can occur in the acute phase as new cells are being generated rapidly.
* A reticulocytosis begins in 3-5 days and peaks in 10 days.  The HCT will rise within 10days.  If it does not, suspect another disorder.  Hypersegmented PMNs disappear in 10-14 days.
* Neurologic abnormalities may take up to 6 months to resolve if ever.  The longer the disease has been present, the worse is the prognosis for recovery.
* Persons with PA have a 2x risk of gastric CA (in some studies).  Screen for occult blood.
 
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}

Revision as of 14:47, 21 September 2012

Macrocytic anemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Macrocytic anemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Macrocytic anemia medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Macrocytic anemia medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Macrocytic anemia medical therapy

CDC on Macrocytic anemia medical therapy

Macrocytic anemia medical therapy in the news

Blogs on Macrocytic anemia medical therapy

Directions to Hospitals Treating Macrocytic anemia

Risk calculators and risk factors for Macrocytic anemia medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Macrocytosis is the enlargement of red blood cells with near-constant haemoglobin concentration, and is defined by a mean corpuscular volume (MCV) of greater than 100 femtolitres (the precise criterion varies between laboratories).

Treatment

  • Folate is administered 1mg QD. Higher doses may be required in malabsorptive syndromes. It is empirically given to those with SCD and those on HD.
  • B12 must be given as a load then maintenance. Most advocate 1000 mcg IM Qweek x4 then 100mcg/month.
  • LDH falls in 2 days. Hypokalemia requiring replacement can occur in the acute phase as new cells are being generated rapidly.
  • A reticulocytosis begins in 3-5 days and peaks in 10 days. The HCT will rise within 10days. If it does not, suspect another disorder. Hypersegmented PMNs disappear in 10-14 days.
  • Neurologic abnormalities may take up to 6 months to resolve if ever. The longer the disease has been present, the worse is the prognosis for recovery.
  • Persons with PA have a 2x risk of gastric CA (in some studies). Screen for occult blood.

References

gl:Anemia megaloblástica he:אנמיה מגלובלסטית it:Anemia megaloblastica sl:Megaloblastna anemija sr:Мегалобластна анемија


Template:WikiDoc Sources